Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NSCLC × Radiofrequency Ablation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 11 Liver Neoplasms 5 Colorectal Neoplasms 3 Cholangiocarcinoma 3 Thyroid Diseases 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Hypertension, Portal 1 Hyperaldosteronism 1 Hepatic Metastasis of Colorectal Cancer 1 HCC 1 Gallbladder Neoplasms 1 Colorectal Cancer Liver Metastases 1 Colonic Neoplasms 1 Cholestasis 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1 Bile Duct Neoplasms 1 Barrett Esophagus 1 Agnosia 1

Interventions

Gefitinib 5 icotinib 4 apatinib 3 anlotinib 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Docetaxel 3 osimertinib 2 dacomitinib 2 camrelizumab 2 aflutinib 2 Thalidomide 2 Drug Therapy 2 Carboplatin 2 spartalizumab 1 pembrolizumab 1 envafolimab 1 Vinorelbine 1 Tyrosine Kinase Inhibitors 1 S 1 (combination) 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Cisplatin 1 Bevacizumab 1 Axitinib 1 Aspirin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01105182 2010-04-16

FACPT

The First Affiliated Hospital of Guangzhou Medical University

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡